表紙
市場調査レポート

Dongkook Pharmaceutical Co., Ltd.:製品パイプライン分析

Dongkook Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014

発行 Global Markets Direct 商品コード 306087
出版日 ページ情報 英文 23 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
Dongkook Pharmaceutical Co., Ltd.:製品パイプライン分析 Dongkook Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
出版日: 2014年06月15日 ページ情報: 英文 23 Pages
概要

当レポートでは、Dongkook Pharmaceutical Co., Ltd.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Dongkook Pharmaceutical Co., Ltd.の基本情報

Dongkook Pharmaceutical Co., Ltd.の概要

  • 主要情報
  • 企業情報

Dongkook Pharmaceutical Co., Ltd.:R&Dの概要

  • 主な治療範囲

Dongkook Pharmaceutical Co., Ltd.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Dongkook Pharmaceutical Co., Ltd.:パイプライン製品の概況

  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ

Dongkook Pharmaceutical Co., Ltd.:薬剤プロファイル

  • goserelin biosimilar
  • triptorelin pamoate biosimilar
  • Asiaticoside Derivatives
  • Gene Re-Combination Proteins
  • Peptide Antibiotics

Dongkook Pharmaceutical Co., Ltd.:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Dongkook Pharmaceutical Co., Ltd.:休止中のプロジェクト

Dongkook Pharmaceutical Co., Ltd.:本社と子会社の所在地

付録

目次
Product Code: GMDHC05009CDB

Global Markets Direct's, 'Dongkook Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Dongkook Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Dongkook Pharmaceutical Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Dongkook Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Dongkook Pharmaceutical Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Dongkook Pharmaceutical Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate Dongkook Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Dongkook Pharmaceutical Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Dongkook Pharmaceutical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Dongkook Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Dongkook Pharmaceutical Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Dongkook Pharmaceutical Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Dongkook Pharmaceutical Co., Ltd. Snapshot
    • Dongkook Pharmaceutical Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Dongkook Pharmaceutical Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline Products Glance
    • Dongkook Pharmaceutical Co., Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Dongkook Pharmaceutical Co., Ltd. - Drug Profiles
    • goserelin biosimilar
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • triptorelin pamoate biosimilar
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Asiaticoside Derivatives
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Gene Re-Combination Proteins
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Peptide Antibiotics
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline Analysis
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline Products by Target
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action
  • Dongkook Pharmaceutical Co., Ltd. - Dormant Projects
  • Dongkook Pharmaceutical Co., Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Dongkook Pharmaceutical Co., Ltd., Key Information
  • Dongkook Pharmaceutical Co., Ltd., Key Facts
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Indication, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Preclinical, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Discovery, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Target, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2014

List of Figures

  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Top 10 Route of Administration, 2014
  • Dongkook Pharmaceutical Co., Ltd. - Pipeline by Top 10 Molecule Type, 2014
Back to Top